Richard van den Broek - Apr 8, 2025 Form 3 Insider Report for Corvus Pharmaceuticals, Inc. (CRVS)

Role
Director
Signature
/s/ Leiv Lea, as Attorney-in-Fact for Richard van den Broek
Stock symbol
CRVS
Transactions as of
Apr 8, 2025
Transactions value $
$0
Form type
3
Date filed
4/9/2025, 05:26 PM
Previous filing
Jun 24, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CRVS Common Stock 160K Apr 8, 2025 See foonote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by HSMR Advisors, LLC, of which the Reporting Person is the sole owner.

Remarks:

Exhibit 24.1 - Power of Attorney